Correlation Between Isofol Medical and Mendus AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Isofol Medical and Mendus AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Isofol Medical and Mendus AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Isofol Medical AB and Mendus AB, you can compare the effects of market volatilities on Isofol Medical and Mendus AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Isofol Medical with a short position of Mendus AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Isofol Medical and Mendus AB.

Diversification Opportunities for Isofol Medical and Mendus AB

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Isofol and Mendus is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Isofol Medical AB and Mendus AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mendus AB and Isofol Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Isofol Medical AB are associated (or correlated) with Mendus AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mendus AB has no effect on the direction of Isofol Medical i.e., Isofol Medical and Mendus AB go up and down completely randomly.

Pair Corralation between Isofol Medical and Mendus AB

Assuming the 90 days trading horizon Isofol Medical AB is expected to generate 2.2 times more return on investment than Mendus AB. However, Isofol Medical is 2.2 times more volatile than Mendus AB. It trades about -0.08 of its potential returns per unit of risk. Mendus AB is currently generating about -0.25 per unit of risk. If you would invest  247.00  in Isofol Medical AB on November 3, 2024 and sell it today you would lose (29.00) from holding Isofol Medical AB or give up 11.74% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Isofol Medical AB  vs.  Mendus AB

 Performance 
       Timeline  
Isofol Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Isofol Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Mendus AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mendus AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Isofol Medical and Mendus AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Isofol Medical and Mendus AB

The main advantage of trading using opposite Isofol Medical and Mendus AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Isofol Medical position performs unexpectedly, Mendus AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mendus AB will offset losses from the drop in Mendus AB's long position.
The idea behind Isofol Medical AB and Mendus AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings